Get the Stockscreener App
14.98
1.71%
-0.26
After Hours:
14.98
Si Bone Inc stock is traded at $14.98, with a volume of 534.05K.
It is down -1.71% in the last 24 hours and down -16.17% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$15.24
Open:
$15.29
24h Volume:
534.05K
Relative Volume:
0.94
Market Cap:
$650.00M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-14.83
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
-4.71%
1M Performance:
-16.17%
6M Performance:
-1.45%
1Y Performance:
-7.64%
1-Day Range:
$14.94
$15.48
1-Week Range:
$14.75
$15.83
52-Week Range:
$12.49
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.98 | 661.28M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Impax Asset Management Group plc Increases Stake in SiBone $SIBN - MarketBeat
More Unpleasant Surprises Could Be In Store For SI-BONE, Inc.'s (NASDAQ:SIBN) Shares After Tumbling 27% - 富途牛牛
Avoiding Lag: Real-Time Signals in (SIBN) Movement - Stock Traders Daily
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026 - The Manila Times
SI-BONE, Inc. to Announce Q4 and Full Year 2025 Financial Results on February 23, 2026 - Quiver Quantitative
Y Intercept Hong Kong Ltd Grows Stake in SiBone $SIBN - MarketBeat
SiBone (NASDAQ:SIBN) Upgraded by TD Cowen to Strong-Buy Rating - MarketBeat
Breakout Watch: What is the next catalyst for SI BONE IncTrade Analysis Report & Intraday High Probability Alerts - baoquankhu1.vn
TD Cowen Initiates Coverage on SI-BONE (SIBN) with a 'Buy' Ratin - GuruFocus
A Glimpse Into The Expert Outlook On SI-BONE Through 5 Analysts - Benzinga
TD Cowen Initiates Coverage on SI-BONE With Buy Rating, $21 Price Target - marketscreener.com
TD Cowen initiates coverage on SI-BONE stock with Buy rating - Investing.com
Discipline and Rules-Based Execution in SIBN Response - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: A 53% Upside Potential as Analysts Strongly Favor a Buy - DirectorsTalk Interviews
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Financial Review: SiBone (NASDAQ:SIBN) vs. Adagio Medical (NASDAQ:ADGM) - Defense World
Jim Cramer on SI-BONE: "This is a great, great speculation" - MSN
Momentum Shift: Will SI BONE Inc benefit from rising consumer demandInsider Selling & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Take Profit: Whats the outlook for Bausch Health Companies Incs sectorMarket Activity Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
ETF Watch: Can SI BONE Inc be recession proofStock Surge & Verified Momentum Stock Ideas - baoquankhu1.vn
Further Weakness as SI-BONE (NASDAQ:SIBN) Drops 12% This Week, Taking Five-year Losses to 39% - 富途资讯
Behavioral Patterns of SIBN and Institutional Flows - Stock Traders Daily
New Highs: Can SI BONE Inc stock weather global recessionJuly 2025 Snapshot & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Aug Intraday: Can SI BONE Inc stock hit record highs againM&A Rumor & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
Stock Market Recap: Is SI BONE Inc. (2K3) stock a top hedge fund pickEarnings Risk Summary & Detailed Earnings Play Strategies - Bộ Nội Vụ
US-based SI-BONE’s preliminary revenue up 15% in Q4 2025 - Medical Buyer
Returns Recap: Will SI BONE Inc stock see PE expansionPortfolio Gains Report & Smart Swing Trading Alerts - Bộ Nội Vụ
SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares of Stock - Defense World
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares - MarketBeat
Dunn (SI-Bone director) sells $425k in SIBN stock By Investing.com - Investing.com Nigeria
Dunn (SI-Bone director) sells $425k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Shares Down 6.7%Here's Why - MarketBeat
Press Release: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - 富途资讯
SIBN Reports Strong Preliminary Q4 U.S. Revenue Growth - GuruFocus
SI-BONE Reports Strong Preliminary Q4 and 2025 Revenue Growth - TipRanks
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - The Manila Times
SI-BONE, Inc. Reports Preliminary Fourth Quarter and Full Year 2025 Revenue Growth | SIBN Stock News - Quiver Quantitative
Aug Movers: Can SI BONE Inc weather a recession2025 Trading Recap & Smart Investment Allocation Insights - baoquankhu1.vn
Assessing SI-BONE (SIBN) Valuation After Jim Cramer Endorsements And New Analyst Coverage - Yahoo Finance
SI-BONE Q4 2026 Earnings Preview: Recent $SIBN Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Does Cramer’s ‘Great, Great Speculation’ Tag Alter SI-BONE’s Risk Narrative and Niche Thesis (SIBN)? - Yahoo Finance
Lobbying Update: $10,000 of SI-BONE INC. lobbying was just disclosed | SIBN Stock News - Quiver Quantitative
EPS Watch: Why SI BONE Inc 2K3 stock attracts HNW investors2025 Biggest Moves & Low Drawdown Trading Techniques - moha.gov.vn
Jim Cramer on SI-BONE: "This is a Great, Great Speculation" - Finviz
Jim Cramer on SI-BONE: “This is a Great, Great Speculation” - Insider Monkey
Can SI BONE Inc. stock hit analyst price targetsDip Buying & Free High Return Stock Watch Alerts - Улправда
FOMO Trade: Will SI BONE Inc. stock see PE expansionQuarterly Portfolio Report & Free Fast Gain Swing Trade Alerts - ulpravda.ru
Why SI BONE Inc. stock attracts high net worth investors2025 Dividend Review & Technical Entry and Exit Tips - ulpravda.ru
Why SI BONE, Inc. stock attracts strong analyst attention - ulpravda.ru
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):